NouriTech breaks ground on new plant to produce Calysta’s FeedKind protein at scale

In Tennessee, NouriTech, a venture formed through investments from Cargill, Calysta, Inc. and several third-party institutions, broke ground on a new thirty-seven acre plant...

Memphis Meats raises $17 million to make meat without the animal

In California, Memphis Meats raised $17 million from a group of investors including Bill Gates, Richard Branson and Cargill to continue developing delicious products,...

TerraVia receives FDA generally recognized as safe letter for Algae Butter

In California, TerraVia Holdings, Inc. received a generally recognized as safe no questions letter from the U.S. Food and Drug Administration for its Algae...

The Impossible Burger debuts on the West Coast

In California, Impossible Foods launched the Impossible Burger in selected West Coast restaurants. Not yet available in stores, the Impossible Burger is a result of...

Copia Agro & Food announces a new $50 million agriculture and food investment fund

In Israel, the Copia Agro & Food fund announced it is raising $50 million to expand its investments in agricultural and food projects developed...

Impossible Foods to make 1 million pounds of plant-based meat per month

In California, Impossible Foods launched its first large-scale production facility to make at least 1 million pounds of plant-based meat per month – enough...

The Beyond Burger goes to Yale

In California, Beyond Meat, announced that its Beyond Burger will be available at Yale University’s thirteen on-campus dining halls; making the 315-year-old Ivy League...

i-Health acquires UP4 Probiotics to drive probiotic category leadership

In Connecticut, i-Health Inc. announced the purchase of the UP4 Probiotic brand from UAS Laboratories, LLC. The UP4 consumer brand incorporates state of the...

USDA grants a license for the first monoclonal antibody therapy to control canine atopic...

In New Jersey, Zoetis Inc. announced that the U.S. Department of Agriculture granted a license for CYTOPOINT, the first monoclonal antibody therapy approved to...

Kaleido Biosciences and CoreBiome accelerate microbiome therapeutic discovery

In Massachusetts, Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, announced an agreement with CoreBiome, a...

Stay connected

0FansLike
8,076FollowersFollow
60SubscribersSubscribe

Latest article

Kraig Biocraft develops spider silk proteins breakthrough

In Michigan, Kraig Biocraft Laboratories, Inc., and its R&D team have achieved a major breakthrough in the construction of DNA encoding for spider silk...

Arctic Biomaterials wins 2018 Innovation Award

In Germany, the Innovation Award “Bio-based Material of the Year 2018” goes to Arctic Biomaterials from Finland for degradable glass fibre reinforced PLA. The...

Nine products nominated for “Hemp Product of the Year”

In Germany, for the first time ever, an innovation award will be presented for the “Hemp Product of the Year”. Nine products were nominated...